These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33468649)

  • 1. Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner.
    Smith AR; Alonso JA; Ayres CM; Singh NK; Hellman LM; Baker BM
    Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for ineffective T-cell responses to MHC anchor residue-improved "heteroclitic" peptides.
    Madura F; Rizkallah PJ; Holland CJ; Fuller A; Bulek A; Godkin AJ; Schauenburg AJ; Cole DK; Sewell AK
    Eur J Immunol; 2015 Feb; 45(2):584-91. PubMed ID: 25471691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasticity in the contribution of T cell receptor variable region residues to binding of peptide-HLA-A2 complexes.
    Smith SN; Sommermeyer D; Piepenbrink KH; Blevins SJ; Bernhard H; Uckert W; Baker BM; Kranz DM
    J Mol Biol; 2013 Nov; 425(22):4496-507. PubMed ID: 23954306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geometrical characterization of T cell receptor binding modes reveals class-specific binding to maximize access to antigen.
    Singh NK; Abualrous ET; Ayres CM; Noé F; Gowthaman R; Pierce BG; Baker BM
    Proteins; 2020 Mar; 88(3):503-513. PubMed ID: 31589793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 14-3-3/SLP76 protein-protein interaction in T-cell receptor signalling: a structural and biophysical characterization.
    Soini L; Leysen S; Davis J; Westwood M; Ottmann C
    FEBS Lett; 2021 Feb; 595(3):404-414. PubMed ID: 33159816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide modulation of class I major histocompatibility complex protein molecular flexibility and the implications for immune recognition.
    Hawse WF; Gloor BE; Ayres CM; Kho K; Nuter E; Baker BM
    J Biol Chem; 2013 Aug; 288(34):24372-81. PubMed ID: 23836912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and kinetic basis for heightened immunogenicity of T cell vaccines.
    Chen JL; Stewart-Jones G; Bossi G; Lissin NM; Wooldridge L; Choi EM; Held G; Dunbar PR; Esnouf RM; Sami M; Boulter JM; Rizkallah P; Renner C; Sewell A; van der Merwe PA; Jakobsen BK; Griffiths G; Jones EY; Cerundolo V
    J Exp Med; 2005 Apr; 201(8):1243-55. PubMed ID: 15837811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4.
    Coles CH; McMurran C; Lloyd A; Hock M; Hibbert L; Raman MCC; Hayes C; Lupardus P; Cole DK; Harper S
    J Biol Chem; 2020 Aug; 295(33):11486-11494. PubMed ID: 32532817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell receptors: tugging on the anchor for a tighter hold on the tumor-associated peptide.
    Dyson J
    Eur J Immunol; 2015 Feb; 45(2):380-2. PubMed ID: 25581444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodies.
    Denkberg G; Klechevsky E; Reiter Y
    J Immunol; 2002 Oct; 169(8):4399-407. PubMed ID: 12370373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamically Driven Allostery in MHC Proteins: Peptide-Dependent Tuning of Class I MHC Global Flexibility.
    Ayres CM; Abualrous ET; Bailey A; Abraham C; Hellman LM; Corcelli SA; Noé F; Elliott T; Baker BM
    Front Immunol; 2019; 10():966. PubMed ID: 31130956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide cargo tunes a network of correlated motions in human leucocyte antigens.
    Hopkins JR; Crean RM; Catici DAM; Sewell AK; Arcus VL; Van der Kamp MW; Cole DK; Pudney CR
    FEBS J; 2020 Sep; 287(17):3777-3793. PubMed ID: 32134551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility.
    Borbulevych OY; Piepenbrink KH; Gloor BE; Scott DR; Sommese RF; Cole DK; Sewell AK; Baker BM
    Immunity; 2009 Dec; 31(6):885-96. PubMed ID: 20064447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2.
    Gagnon SJ; Turner RV; Shiue MG; Damirjian M; Biddison WE
    Mol Immunol; 2006 Feb; 43(4):346-56. PubMed ID: 16310048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining folding and binding properties of the C-terminal SH2 domain of SHP2.
    Nardella C; Malagrinò F; Pagano L; Rinaldo S; Gianni S; Toto A
    Protein Sci; 2021 Dec; 30(12):2385-2395. PubMed ID: 34605082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of carboxypeptidase T complexes with transition-state analogs.
    Akparov VK; Timofeev VI; Khaliullin IG; Švedas V; Kuranova IP; Rakitina TV
    J Biomol Struct Dyn; 2018 Nov; 36(15):3958-3966. PubMed ID: 29129130
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.
    Hoppes R; Oostvogels R; Luimstra JJ; Wals K; Toebes M; Bies L; Ekkebus R; Rijal P; Celie PH; Huang JH; Emmelot ME; Spaapen RM; Lokhorst H; Schumacher TN; Mutis T; Rodenko B; Ovaa H
    J Immunol; 2014 Nov; 193(10):4803-13. PubMed ID: 25311806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.
    Sullivan LC; Walpole NG; Farenc C; Pietra G; Sum MJW; Clements CS; Lee EJ; Beddoe T; Falco M; Mingari MC; Moretta L; Gras S; Rossjohn J; Brooks AG
    J Biol Chem; 2017 Dec; 292(51):21149-21158. PubMed ID: 28972140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
    Yang X; Chen G; Weng NP; Mariuzza RA
    J Biol Chem; 2017 Nov; 292(45):18618-18627. PubMed ID: 28931605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G196 epitope tag system: a novel monoclonal antibody, G196, recognizes the small, soluble peptide DLVPR with high affinity.
    Tatsumi K; Sakashita G; Nariai Y; Okazaki K; Kato H; Obayashi E; Yoshida H; Sugiyama K; Park SY; Sekine J; Urano T
    Sci Rep; 2017 Mar; 7():43480. PubMed ID: 28266535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.